Alexion Pharmaceuticals (ALXN) agrees to buy privately-held biotech firm Enobia for $1.08B in...

|About: Alexion Pharmaceuticals,... (ALXN)|By:, SA News Editor

Alexion Pharmaceuticals (ALXN) agrees to buy privately-held biotech firm Enobia for $1.08B in cash - with $610M paid up front and the rest after various regulatory and sales milestones are hit. Enobia is focused on therapies treating patients with ultra-rare, life-threatening genetic disorders. Shares -1.3% AH. (PR)